Skip to main content
Comparison of ADC metrics and their association with outcome for patients with newly diagnosed glioblastoma being treated with radiation therapy, temozolomide, erlotinib and bevacizumab
Published Web Location
http://europepmc.org/articles/PMC4311062?pdf=renderNo data is associated with this publication.
Abstract
© 2014 The Author(s) To evaluate metrics that describe changes in apparent diffusion coefficient (ADC) and to examine their association with clinical outcome for patients with newly diagnosed GBM who were participating in a Phase II clinical trial of treat
Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.